Beta Drugs fundamental analysis
BETA
1549.3
21.70 (-1.38%)Last updated on 19 Jan, 2026 | 15:31 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Beta Drugs Fundamentals
P/E Ratio
37.39
P/B Ratio
8.05
Div. Yield
0
Sector P/E
69.39
Sector P/B
0.98
Sec. Div. Yield
0.57
Beta Drugs Fundamentals is currently trading with a P/E Ratio of 37.39, compared to the sector average of 69.39. Its P/B Ratio stands at 8.05, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.
Beta Drugs Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Beta Drugs reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
